IMMUNIC, INC. — Director's Dealing 2016

Jun 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2016-06-03

Reporting Person: Winters Terence E. (Director, Co-Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-03	Common Stock	G	2000	—	Disposed	184966	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	119964	Indirect